Assessment of Diabetes Point-of-Care Tests in the Peruvian Amazon
2015-05-17 10:46:45 - 2015-05-17 10:46:45
Diagnosing and monitoring the control of diabetes mellitus is a challenge in the Peruvian Amazon. The current gold standard for diagnosing type 2 diabetes is to analyze HbA1C levels using laboratory-based reference methods. These tests are often expensive and require samples to be shipped to a laboratory for analysis, which is not feasible for health posts in isolated communities in the Peruvian Amazon. Point-of-care (POC) devices offer a potential solution for health posts to obtain HbA1C levels whenever a patient visits the clinic. However, the evidence is mixed regarding whether POC devices are accurate enough to aid in clinical decision making. Thus, the overall aim of this study is to evaluate the performance of the Alere Afinion and the DCA Vantage POC devices in the Peruvian Amazon by comparing the HbA1C results from the POC devices to laboratory-based reference methods.